Nutritional controls of food reward

Canadian Journal of Diabetes

Volumn 37, Issue 4, 2013, Pages 260-268

  Fernandes, Maria F ^a,b   Sharma, Sandeep ^a,b   Hryhorczuk, Cecile ^a,b   Auguste, Stephanie ^a,b   Fulton, Stephanie ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Dopamine; Feeding; Ghrelin; Hedonic; Insulin; Leptin; Nucleus accumbens; Obesity; Reinforcement; Striatum

Indexed keywords

AMINO ACID; CABERGOLINE; CHOLECYSTOKININ; DOPAMINE; FATTY ACID; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; LEPTIN; NEUROTRANSMITTER; PEPTIDE YY;

APPETITE; BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN FUNCTION; FOOD; FOOD INTAKE; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; HUMAN; LIPID DIET; MACRONUTRIENT; NEUROTRANSMISSION; NONHUMAN; NUTRITION; OBESITY; REGULATORY MECHANISM; REVIEW; REWARD; SUGAR INTAKE; ANIMAL; BIOLOGICAL MODEL; EATING; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; APPETITE; EATING; FOOD; HUMANS; MODELS, NEUROLOGICAL; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; REWARD;

EID: 84881236151     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcjd.2013.04.004     Document Type: Review

References (151)

1. Thaler J.P., Choi S.J., Schwartz M.W., Wisse B.E. Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front Neuroendocrinol 2010, 31:79-84.
2. Fulton S. Appetite and reward. Front Neuroendocrinol 2010, 31:85-103.
3. Davis C., Strachan S., Berkson M. Sensitivity to reward: implications for overeating and overweight. Appetite 2004, 42:131-138.
4. Rothemund Y., Preuschhof C., Bohner G., et al. Differential activation of the dorsal striatum by high-calorie visual food stimuli in obese individuals. NeuroImage 2007, 37:410-421.
5. Stoeckel L.E., Weller R.E., Cook E.W., Twieg D.B., Knowlton R.C., Cox J.E. Widespread reward-system activation in obese women in response to pictures of high-calorie foods. NeuroImage 2008, 41:636-647.
6. Martin L.E., Holsen L.M., Chambers R.J., et al. Neural mechanisms associated with food motivation in obese and healthy weight adults. Obesity 2009, 18:254-260.
7. Skinner B.F. The Behavior of organisms: An experimental analysis 1938, Appelton-Century, New York.
8. Hodos W. Progressive ratio as a measure of reward strength. Science (New York, NY) 1961, 134:943-944.
9. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addiction Biol 2007, 12:227-462.
10. Berridge K.C. Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns. Neurosci Biobehav Rev Mar 2000, 24:173-198.
11. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Ann Rev Neurosci 2006, 29:565-598.
12. Palmiter R.D. Dopamine signaling in the dorsal striatum is essential for motivated behaviors: lessons from dopamine-deficient mice. Ann NY Acad Sci 2008, 1129:35-46.
13. Hernandez L., Hoebel B. Feeding and hypothalamic stimulation increase dopamine turnover in the accumbens. Physiol Behav 1988, 44:599-606.
14. Bassareo V., Di Chiara G. Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. Eur J Neurosci 1999, 11:4389-4397.
15. Baldo B.A., Kelley A.E. Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding. Psychopharmacology (Berl) 2007, 191:439-459.
16. Geiger B.M., Behr G.G., Frank L.E., et al. Evidence for defective mesolimbic dopamine exocytosis in obesity-prone rats. Faseb J 2008, 22:2740-2746.
17. Davis J.F., Tracy A.L., Schurdak J.D., et al. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 2008, 122:1257-1263.
18. Wang G.-J., Volkow N.D., Logan J., et al. Brain dopamine and obesity. The Lancet 2001, 357:354-357.
19. Fulton S., Pissios P., Manchon R.P., et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006, 51:811-822.
20. Sharma S., Fulton S. Diet-induced obesity promotes depressive-like behaviour that is associated with neural adaptations in brain reward circuitry. Int J Obes (Lond) 2013, 37:382-389.
21. Sharma S., Fernandes M.F., Fulton S. Adaptations in brain reward circuitry underlie palatable food cravings and anxiety induced by high-fat diet withdrawal. Int J Obes (Lond) 2012, 1-9.
22. Johnson P.M., Kenny P.J. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010, 13:63-641.
23. Gibson C.D., Karmally W., McMahon D.J., Wardlaw S.L., Korner J. Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults. Diabetes Obes Metab 2012, 14:335-340.
24. Beninger R.J., Cheng M., Hahn B.L., et al. Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats. Psychopharmacology 1987, 92:343-349.
25. Beninger R.J., Hoffman D.C., Mazurski E.J. Receptor subtype-specific dopaminergic agents and conditioned behavior. Neurosci Biobehav Rev 1989, 13:113-122.
26. MacDonald A.F., Billington C.J., Levine A.S. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens. Brain Res 2004, 1018:78-85.
27. Aberman J.E., Ward S.J., Salamone J.D. Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance. Pharmacol Biochem Behav 1998, 61:341-348.
28. Zhang M., Balmadrid C., Kelley A.E. Nucleus accumbens opioid, GABaergic, and dopaminergic modulation of palatable food motivation: contrasting effects revealed by a progressive ratio study in the rat. Behavioral Neurosci 2003, 117:202-211.
29. Richardson N.R., Gratton A. Changes in medial prefrontal cortical dopamine levels associated with response-contingent food reward: an electrochemical study in rat. JNeurosci 1998, 18:9130-9138.
30. Pratt W.E., Kelley A.E. Nucleus accumbens acetylcholine regulates appetitive learning and motivation for food via activation of muscarinic receptors. Behavioral Neurosci 2004, 118:730-739.
31. Pratt W.E., Blackstone K. Nucleus accumbens acetylcholine and food intake: decreased muscarinic tone reduces feeding but not food-seeking. Behavioural Brain Res 2009, 198:252-257.
32. Sharf R., McKelvey J., Ranaldi R. Blockade of muscarinic acetylcholine receptors in the ventral tegmental area prevents acquisition of food-rewarded operant responding in rats. Psychopharmacology 2006, 186:113-121.
33. Perry M.L., Andrzejewski M.E., Bushek S.M., Baldo B.A. Intra-accumbens infusion of a muscarinic antagonist reduces food intake without altering the incentive properties of food-associated cues. Behavioral Neurosci 2010, 124(1):44-54.
34. Grottick A.J., Fletcher P.J., Higgins G.A. Studies to investigate the role of 5-HT(2C) receptors on cocaine- and food-maintained behavior. JPharmacol Exp Ther 2000, 295:1183-1191.
35. Fletcher P.J., Azampanah A., Korth K.M. Activation of 5-HT(1B) receptors in thenucleus accumbens reduces self-administration of amphetamine on a progressive ratio schedule. Pharmacol Biochem Behav 2002, 71:717-725.
36. Parker J.G., Wanat M.J., Soden M.E., et al. Attenuating GABA(A) receptor signaling in dopamine neurons selectively enhances reward learning and alters risk preference in mice. JNeurosci 2011, 31:17103-17112.
37. Wirtshafter D., Stratford T.R. Evidence for motivational effects elicited by activation of GABA-A or dopamine receptors in the nucleus accumbens shell. Pharmacol Biochem Behav 2010, 96:342-346.
38. Stratford T.R., Wirtshafter D. Effects of muscimol, amphetamine, and DAMGO injected into the nucleus accumbens shell on food-reinforced lever pressing by undeprived rats. Pharmacol Biochem Behav 2012, 101:499-503.
39. Wojnicki F.H., Roberts D.C., Corwin R.L. Effects of baclofen on operant performance for food pellets and vegetable shortening after a history of binge-type behavior in non-food deprived rats. Pharmacol Biochem Behav 2006, 84:197-206.
40. Mead A.N., Stephens D.N. Selective disruption of stimulus-reward learning in glutamate receptor gria1 knock-out mice. JNeurosci 2003, 23:1041-1048.
41. Paterson N.E., Markou A. The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 2005, 179:255-261.
42. Gass J.T., Osborne M.P., Watson N.L., Brown J.L., Olive M.F. mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology 2009, 34:820-833.
43. Higgs S., Barber D.J., Cooper A.J., Terry P. Differential effects of two cannabinoid receptor agonists on progressive ratio responding for food and free-feeding in rats. Behav Pharmacol 2005, 16:389-393.
44. Solinas M., Goldberg S.R. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 2005, 30:2035-2045.
45. Maccioni P., Pes D., Carai M.A., Gessa G.L., Colombo G. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats. Behav Pharmacol 2008, 19:197-209.
46. Ward S.J., Dykstra L.A. The role of CB1 receptors in sweet versus fat reinforcement: effect of CB1 receptor deletion, CB1 receptor antagonism (SR141716A) and CB1 receptor agonism (CP-55940). Behav Pharmacol 2005, 16:381-388.
47. Mahler S.V., Smith K.S., Berridge K.C. Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology 2007, 32:2267-2278.
48. Hernandez G., Cheer J.F. Effect of CB1 receptor blockade on food-reinforced responding and associated nucleus accumbens neuronal activity in rats. JNeurosci 2012, 32:11467-11477.
49. Nair S.G., Adams-Deutsch T., Pickens C.L., Smith D.G., Shaham Y. Effects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-reinforced operant responding and reinstatement of food seeking in rats. Psychopharmacology 2009, 205:129-140.
50. Guesdon B., Paradis E., Samson P., Richard D. Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. Am J Physiol Regul Integr Comp Physiol 2009, 296:R469-R475.
51. Lopez C.A., Guesdon B., Baraboi E.D., Roffarello B.M., Hetu M., Richard D. Involvement of the opioid system in the orexigenic and hedonic effects of melanin-concentrating hormone. Am J Physiol Regul Integr Comp Physiol 2011, 301:R1105-R1111.
52. Sharf R., Sarhan M., Brayton C.E., Guarnieri D.J., Taylor J.R., DiLeone R.J. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biological Psych 2010, 67:753-760.
53. Thorpe A.J., Cleary J.P., Levine A.S., Kotz C.M. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology 2005, 182:75-83.
54. Thorpe A.J., Mullett M.A., Wang C., Kotz C.M. Peptides that regulate food intake: regional, metabolic, and circadian specificity of lateral hypothalamic orexin A feeding stimulation. Am J Physiol 2003, 284:R1409-R1417.
55. Borgland S.L., Chang S.J., Bowers M.S., et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. JNeurosci 2009, 29:11215-11225.
56. Richards J.K., Simms J.A., Steensland P., et al. Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology 2008, 199:109-117.
57. Borgland S.L., Taha S.A., Sarti F., Fields H.L., Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 2006, 49:589-601.
58. Cottone P., Sabino V., Roberto M., et al. CRF system recruitment mediates dark side of compulsive eating. Proc Natl Acad Sci U S A 2009, 106:20016-20020.
59. Kelley A.E., Cador M., Stinus L., Le Moal M. Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding. Psychopharmacology 1989, 97:243-252.
60. Rossitch E., King R.A., Luttinger D., Nemeroff C.B. Behavioral effects of neurotensin: operant responding and assessment of 'anhedonia'. Eur J Pharmacol 1989, 163:119-122.
61. Tracy A.L., Clegg D.J., Johnson J.D., Davidson T.L., Benoit S.C. The melanocortin antagonist AgRP (83-132) increases appetitive responding for a fat, but not a carbohydrate, reinforcer. Pharmacol Biochem Behav 2008, 89:263-271.
62. Vaughan C., Moore M., Haskell-Luevano C., Rowland N.E. Food motivated behavior of melanocortin-4 receptor knockout mice under a progressive ratio schedule. Peptides 2006, 27:2829-2835.
63. Jewett D.C., Cleary J., Levine A.S., Schaal D.W., Thompson T. Effects of neuropeptide Y, insulin, 2-deoxyglucose, and food deprivation on food-motivated behavior. Psychopharmacology 1995, 120:267-271.
64. Brown C.M., Fletcher P.J., Coscina D.V. Neuropeptide Y-induced operant responding for sucrose is not mediated by dopamine. Peptides 1998, 19:1667-1673.
65. Skibicka K.P., Shirazi R.H., Hansson C., Dickson S.L. Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward. Endocrinology 2012, 153:1194-1205.
66. Brown C.M., Coscina D.V., Fletcher P.J. The rewarding properties of neuropeptide Y in perifornical hypothalamus vs. nucleus accumbens. Peptides 2000, 21:1279-1287.
67. Burdakov D., Gerasimenko O., Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. JNeurosci 2005, 25:2429-2433.
68. Kong D., Vong L., Parton L.E., et al. Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab 2010, 12:545-552.
69. Marston O.J., Hurst P., Evans M.L., Burdakov D.I., Heisler L.K. Neuropeptide Y cells represent a distinct glucose-sensing population in the lateral hypothalamus. Endocrinology 2011, 152:4046-4052.
70. Karnani M.M., Venner A., Jensen L.T., Fugger L., Burdakov D. Direct and indirect control of orexin/hypocretin neurons by glycine receptors. JPhysiol 2011, 589(Pt 3):639-651.
71. Jo Y.H., Chen Y.J., Chua S.C., Talmage D.A., Role L.W. Integration of endocannabinoid and leptin signaling in an appetite-related neural circuit. Neuron 2005, 48:1055-1066.
72. Leinninger G.M., Jo Y.H., Leshan R.L., et al. Leptin acts via leptin receptor-expressing lateral hypothalamic neurons to modulate the mesolimbic dopamine system and suppress feeding. Cell Metab 2009, 10:89-98.
73. Bernardis L.L., Bellinger L.L. The lateral hypothalamic area revisited: ingestive behavior. Neurosci Biobehav Rev 1996, 20:189-287.
74. Carr K.D., Wolinsky T.D. Chronic food restriction and weight loss produce opioid facilitation of perifornical hypothalamic self-stimulation. Brain Res 1993, 607:141-148.
75. Fulton S., Woodside B., Shizgal P. Modulation of brain reward circuitry by leptin. Science (New York, NY) 2000, 287:125-128.
76. Fulton S., Richard D., Woodside B., Shizgal P. Interaction of CRH and energy balance in the modulation of brain stimulation reward. Behavioral Neurosci 2002, 116:651-659.
77. Fulton S., Richard D., Woodside B., Shizgal P. Food restriction and leptin impact brain reward circuitry in lean and obese Zucker rats. Behav Brain Res 2004, 155:319-329.
78. Fulton S., Woodside B., Shizgal P. Does neuropeptide Y contribute to the modulation of brain stimulation reward by chronic food restriction?. Behav Brain Res 2002, 134:157-164.
79. Fulton S., Woodside B., Shizgal P. Potentiation of brain stimulation reward by weight loss: evidence for functional heterogeneity in brain reward circuitry. Behav Brain Res 2006, 174:56-63.
80. Pissios P., Frank L., Kennedy A.R., et al. Dysregulation of the mesolimbic dopamine system and reward in MCH-/- mice. Biol Psych 2008, 64:184-191.
81. Zheng H., Patterson L.M., Berthoud H.R. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. JNeurosci 2007, 27:11075-11082.
82. Koutsari C., Karpe F., Humphreys S.M., Frayn K.N., Hardman A.E. Plasma leptin is influenced by diet composition and exercise. Int J Obes Relat Metab Disord 2003, 27:901-906.
83. Myers M.G., Heymsfield S.B., Haft C., et al. Challenges and opportunities of defining clinical leptin resistance. Cell Metab 2012, 15:150-156.
84. Figlewicz D.P., Bennett J.L., Naleid A.M., Davis C., Grimm J.W. Intraventricular insulin and leptin decrease sucrose self-administration in rats. Physiol Behav 2006, 89:611-616.
85. Sharma S., Hryhorczuk C., Fulton S. Progressive-ratio responding for palatable high-fat and high-sugar food in mice. JVis Exp 2012, (63):e3754.
86. Figlewicz D.P., Bennett J., Evans S.B., Kaiyala K., Sipols A.J., Benoit S.C. Intraventricular insulin and leptin reverse place preference conditioned with high-fat diet in rats. Behavioral Neurosci 2004, 118:479-487.
87. Farooqi I.S., Bullmore E., Keogh J., Gillard J., O'Rahilly S., Fletcher P.C. Leptin regulates striatal regions and human eating behavior. Science (New York, NY) 2007, 317:1355.
88. Szczypka M.S., Rainey M.A., Palmiter R.D. Dopamine is required for hyperphagia in Lep(ob/ob) mice. Nat Genet 2000, 25:102-104.
89. Scislowski P.W., Tozzo E., Zhang Y., Phaneuf S., Prevelige R., Cincotta A.H. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Int J Obes Relat Metab Disord 1999, 23:425-431.
90. Figlewicz D.P., Evans S.B., Murphy J., Hoen M., Baskin D.G. Expression of receptors for insulin and leptin in the ventral tegmental area/substantia nigra (VTA/SN) of the rat. Brain Res 2003, 964:107-115.
91. Scott M.M., Lachey J.L., Sternson S.M., et al. Leptin targets in the mouse brain. JComp Neurol 2009, 514:518-532.
92. Hommel J.D., Trinko R., Sears R.M., et al. Leptin receptor signaling in midbrain dopamine neurons regulates feeding. Neuron 2006, 51:801-810.
93. Krugel U., Schraft T., Kittner H., Kiess W., Illes P. Basal and feeding-evoked dopamine release in the rat nucleus accumbens is depressed by leptin. Eur J Pharmacol 2003, 482:185-187.
94. Davis J.F., Choi D.L., Schurdak J.D., et al. Leptin regulates energy balance and motivation through action at distinct neural circuits. Biol Psych 2011, 69:668-674.
95. Liu J., Perez S.M., Zhang W., Lodge D.J., Lu X.Y. Selective deletion of the leptin receptor in dopamine neurons produces anxiogenic-like behavior and increases dopaminergic activity in amygdala. Mol Psych 2011, 16:1024-1038.
96. Bruning J.C., Gautam D., Burks D.J., et al. Role of brain insulin receptor in control of body weight and reproduction. Science (New York, NY) 2000, 289:2122-2125.
97. Figlewicz D.P., Bennett J.L., Aliakbari S., Zavosh A., Sipols A.J. Insulin acts atdifferent CNS sites to decrease acute sucrose intake and sucrose self-administration in rats. Am J Physiol 2008, 295:R388-R394.
98. Konner A.C., Hess S., Tovar S., et al. Role for insulin signaling in catecholaminergic neurons in control of energy homeostasis. Cell Metab 2011, 13:720-728.
99. Potter G.M., Moshirfar A., Castonguay T.W. Insulin affects dopamine overflow in the nucleus accumbens and the striatum. Physiol Behav 1999, 65:811-816.
100. Benedict C., Hallschmid M., Schultes B., Born J., Kern W. Intranasal insulin to improve memory function in humans. Neuroendocrinology 2007, 86:136-142.
101. Anthony K., Reed L.J., Dunn J.T., et al. Attenuation of insulin-evoked responses in brain networks controlling appetite and reward in insulin resistance: the cerebral basis for impaired control of food intake in metabolic syndrome?. Diabetes 2006, 55:2986-2992.
102. Garcia B.G., Wei Y., Moron J.A., Lin R.Z., Javitch J.A., Galli A. Akt is essential for insulin modulation of amphetamine-induced human dopamine transporter cell-surface redistribution. Mol Pharmacol 2005, 68:102-109.
103. Williams J.M., Owens W.A., Turner G.H., et al. Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 2007, 5:e274.
104. Benedict C., Hallschmid M., Schmitz K., et al. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology 2007, 32:239-243.
105. Monteleone P., Bencivenga R., Longobardi N., Serritella C., Maj M. Differential responses of circulating ghrelin to high-fat or high-carbohydrate meal in healthy women. JClin Endocrinol Metab 2003, 88:5510-5514.
106. Jerlhag E., Egecioglu E., Dickson S.L., Engel J.A. Ghrelin receptor antagonism attenuates cocaine- and amphetamine-induced locomotor stimulation, accumbal dopamine release, and conditioned place preference. Psychopharmacology 2010, 211:415-422.
107. Abizaid A., Liu Z.W., Andrews Z.B., et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. JClin Invest 2006, 116:3229-3239.
108. Egecioglu E., Jerlhag E., Salome N., et al. Ghrelin increases intake of rewarding food in rodents. Addiction Biol 2010, 15:304-311.
109. Naleid A.M., Grace M.K., Cummings D.E., Levine A.S. Ghrelin induces feeding in the mesolimbic reward pathway between the ventral tegmental area and the nucleus accumbens. Peptides 2005, 26:2274-2279.
110. Skibicka K.P., Hansson C., Alvarez-Crespo M., Friberg P.A., Dickson S.L. Ghrelin directly targets the ventral tegmental area to increase food motivation. Neuroscience 2011, 180:129-137.
111. Malik S., McGlone F., Bedrossian D., Dagher A. Ghrelin modulates brain activity in areas that control appetitive behavior. Cell Metab 2008, 7:400-409.
112. Monteleone P., Piscitelli F., Scognamiglio P., et al. Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. JClin Endocrinol Metab 2012, 97:E917-E924.
113. Troisi A., Di Lorenzo G., Lega I., et al. Plasma ghrelin in anorexia, bulimia, and binge-eating disorder: relations with eating patterns and circulating concentrations of cortisol and thyroid hormones. Neuroendocrinology 2005, 81:259-266.
114. Moran T.H., Bi S. Hyperphagia and obesity in OLETF rats lacking CCK-1 receptors. Philos Trans R Soc Lond B Biol Sci 2006, 361:1211-1218.
115. Hokfelt T., Rehfeld J.F., Skirboll L., Ivemark B., Goldstein M., Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 1980, 285:476-478.
116. Hsiao S., Deupree D. Cholecystokinin and bombesin effects on rewarded and nonrewarded operants. Peptides 1983, 4:1-3.
117. Babcock A.M., Livosky M., Avery D.D. Cholecystokinin and bombesin suppress operant responding for food reward. Pharmacol Biochem Behav 1985, 22:893-895.
118. Hajnal A., Acharya N.K., Grigson P.S., Covasa M., Twining R.C. Obese OLETF rats exhibit increased operant performance for palatable sucrose solutions and differential sensitivity to D2 receptor antagonism. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1846-R1854.
119. Dossat A.M., Lilly N., Kay K., Williams D.L. Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake. JNeurosci 2011, 31:14453-14457.
120. Alhadeff A.L., Rupprecht L.E., Hayes M.R. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 2012, 153:647-658.
121. Dickson S.L., Shirazi R.H., Hansson C., Bergquist F., Nissbrandt H., Skibicka K.P. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. JNeurosci 2012, 32:4812-4820.
122. Batterham R.L., Cowley M.A., Small C.J., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002, 418:650-654.
123. Batterham R.L., Ffytche D.H., Rosenthal J.M., et al. PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 2007, 450:106-109.
124. Levin B.E., Routh V.H., Kang L., Sanders N.M., Dunn-Meynell A.A. Neuronal glucosensing: what do we know after 50 years?. Diabetes 2004, 53:2521-2528.
125. Thompson D.A., Campbell R.G. Hunger in humans induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. Science (New York, NY) 1977, 198:1065-1068.
126. Page K.A., Seo D., Belfort-DeAguiar R., et al. Circulating glucose levels modulate neural control of desire for high-calorie foods in humans. JClin Invest 2011, 121:4161-4169.
127. Levin B.E. Glucose-regulated dopamine release from substantia nigra neurons. Brain Res 2000, 874:158-164.
128. Marinelli S., Bernardi G., Giacomini P., Mercuri N.B. Pharmacological identification of the K(+) currents mediating the hypoglycemic hyperpolarization of rat midbrain dopaminergic neurones. Neuropharmacology 2000, 39:1021-1028.
129. Oliveira-Maia A.J., Roberts C.D., Walker Q.D., et al. Intravascular food reward. PLoS One 2011, 6:e24992.
130. Hardman C.A., Herbert V.M., Brunstrom J.M., Munafo M.R., Rogers P.J. Dopamine and food reward: effects of acute tyrosine/phenylalanine depletion on appetite. Physiol Behav 2012, 105:1202-1207.
131. McTavish S.F., Cowen P.J., Sharp T. Effect of a tyrosine-free amino acid mixture on regional brain catecholamine synthesis and release. Psychopharmacology 1999, 141:182-188.
132. Fernstrom J.D. Carbohydrate ingestion and brain serotonin synthesis: relevance to a putative control loop for regulating carbohydrate ingestion, and effects of aspartame consumption. Appetite 1988, 11(Suppl 1):35-41.
133. Pagoto S.L., Spring B., McChargue D., et al. Acute tryptophan depletion and sweet food consumption by overweight adults. Eat Behav 2009, 10:36-41.
134. Mitchell R.W., Hatch G.M. Fatty acid transport into the brain: of fatty acid fables and lipid tails. Prostaglandins Leukot Essent Fatty Acids 2011, 85:293-302.
135. Artmann A., Petersen G., Hellgren L.I., et al. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 2008, 1781:200-212.
136. Karmi A., Iozzo P., Viljanen A., et al. Increased brain fatty acid uptake in metabolic syndrome. Diabetes 2010, 59:2171-2177.
137. Obici S., Feng Z., Morgan K., Stein D., Karkanias G., Rossetti L. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 2002, 51:271-275.
138. Schwinkendorf D.R., Tsatsos N.G., Gosnell B.A., Mashek D.G. Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism. Int J Obes (Lond) 2011, 35:336-344.
139. Kleinridders A., Schenten D., Konner A.C., et al. MyD88 signaling in the CNS isrequired for development of fatty acid-induced leptin resistance and diet-induced obesity. Cell Metab 2009, 10:249-259.
140. Benoit S.C., Kemp C.J., Elias C.F., et al. Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. JClin Invest 2009, 119:2577-2589.
141. de Araujo I.E., Oliveira-Maia A.J., Sotnikova T.D., et al. Food reward in the absence of taste receptor signaling. Neuron 2008, 57:930-941.
142. de Araujo I.E., Ferreira J.G., Tellez L.A., Ren X., Yeckel C.W. The gut-brain dopamine axis: a regulatory system for caloric intake. Physiology Behav 2012, 106:394-399.
143. Geiger B.M., Haburcak M., Avena N.M., Moyer M.C., Hoebel B.G., Pothos E.N. Deficits of mesolimbic dopamine neurotransmission in rat dietary obesity. Neuroscience 2009, 159:1193-1199.
144. Stice E., Spoor S., Bohon C., Small D.M. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science (New York, NY) 2008, 322:449-452.
145. Burger K.S., Stice E. Frequent ice cream consumption is associated with reduced striatal response to receipt of an ice cream-based milkshake. Am J Clin Nutr 2012, 95:810-817.
146. Teegarden S.L., Nestler E.J., Bale T.L. Delta FosB-mediated alterations in dopamine signaling are normalized by a palatable high-fat diet. Biol Psychiatry 2008, 64:941-950.
147. Vucetic Z., Carlin J.L., Totoki K., Reyes T.M. Epigenetic dysregulation of the dopamine system in diet-induced obesity. JNeurochem 2012, 120:891-898.
148. Teegarden S.L., Scott A.N., Bale T.L. Early life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signaling. Neuroscience 2009, 162:924-932.
149. Vucetic Z., Kimmel J., Reyes T.M. Chronic high-fat diet drives postnatal epigenetic regulation of mu-opioid receptor in the brain. Neuropsychopharmacology 2011, 36:1199-1206.
150. Naef L., Srivastava L., Gratton A., Hendrickson H., Owens S.M., Walker C.D. Maternal high fat diet during the perinatal period alters mesocorticolimbic dopamine in the adult rat offspring: reduction in the behavioral responses to repeated amphetamine administration. Psychopharmacology (Berl) 2008, 197:83-94.
151. Naef L., Moquin L., Dal Bo G., Giros B., Gratton A., Walker C.D. Maternal high-fat intake alters presynaptic regulation of dopamine in the nucleus accumbens and increases motivation for fat rewards in the offspring. Neuroscience 2011, 176:225-236.